Association between chemotherapy and the risk of developing breast cancer-related lymphedema: a nationwide retrospective cohort study
Chemotherapy administration following a diagnosis of breast cancer increases the risk of BCRL. Therefore, vigilant monitoring for BCRL, particularly in patients undergoing chemotherapy with taxanes, antimetabolites, or anthracyclines, is warranted during follow-up.
Authors
- Seong Min Chun (ORCID: https://orcid.org/0000-0002-2174-8742)
- Ja‐Ho Leigh (ORCID: https://orcid.org/0000-0003-0465-6392)
- Sung Hoon Jeong (ORCID: https://orcid.org/0000-0002-5581-7929)
- Mira Choi (ORCID: https://orcid.org/0000-0003-2464-9675)
- M.S. Kim (ORCID: https://orcid.org/0000-0003-4436-1361)
- Hyunji Lee (ORCID: https://orcid.org/0000-0002-9021-5632)
Institutions
- Yonsei University (KR)
- Soonchunhyang University Hospital Seoul (KR)
- Seoul National University Hospital (KR)
- Inje University Ilsan Paik Hospital (KR)
- National University College (PR)
- National Rehabilitation Center (KR)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1007/s00520-025-09169-3
- Citations
- 3
- Primary Topic
- Lymphatic System and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Seoul National University
- Ministry of Land, Infrastructure and Transport